Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

4 Reasons to Buy Novavax in 2021

TheMotleyFool

0 0

If you thought the market was crazy about vaccine stocks this year, just wait until 2021. As coronavirus vaccines are distributed to the public and a slew of companies prepare to report new revenue from sales, 2020's winners could go big yet again.

Novavax (NASDAQ: NVAX) is one such stock. The company has gained about 3,130% year to date. It probably won't grow by that much next year, but that doesn't mean new investors are too late to enjoy significant gains. In my view, there are four solid reasons why Novavax will be worth a buy next year.